Iridium (IRMD) | Stock Overview & Key Data
Iridium Performance Comparison
Stock Range
Today's Range
Low: $70.23
High: $73.40
on September 18, 2025
52 Week Range
Low: $46.86
High: $74.43
on October 31, 2024
on September 11, 2025
All-Time High: $74.43 on September 11, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$909.0M
EPS
1.61
P/E Ratio (TTM)
44.39
Forward P/E
40.83
P/B Ratio
9.64
PEG Ratio
2.89
Div. Yield
1.15%
ROE
23.75%
Beta
1.027
Debt to Equity
0.00
Financial Highlights
Profitability
Gross Margin
78.17%
Operating Margin
33.26%
Profit Margin
26.61%
Returns and Earnings
Return on Assets (TTM)
15.15%
Return on Equity (TTM)
23.75%
EBITDA
$24.6M
Net Income (TTM)
$20.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$6.11
Quarterly Revenue Growth (YoY)
13.80%
Quarterly Earnings Growth (YoY)
17.80%
Dividend Information
Last 12-Month Dividend
$0.81
Current Dividend Yield
1.15%
3-Year Average Dividend Yield
0.75%
3-Year Average Annual Dividend
$0.88
3-Year Total Dividends
$2.64
Ex-Dividend Date
August 18, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Iridium IRMD | 908.97M Small-cap | -2.54% | 3.24% | 23.83% | 39.06% | 31.74% | 50.85% | 133.41% | 244.01% |
| Abbott Laboratories ABT | 232.75B Mega-cap | 1.45% | 3.30% | 1.63% | 6.55% | 18.63% | 18.36% | 33.66% | 30.08% |
| Boston Scientific BSX | 147.98B Large-cap | -5.86% | -4.68% | -3.10% | -1.00% | 9.90% | 17.05% | 152.52% | 163.07% |
| Enovis ENOV | 1.90B Small-cap | 5.03% | 12.25% | 8.19% | -14.97% | -25.12% | -24.04% | -30.98% | -36.96% |
| Artivion AORT | 1.88B Small-cap | -2.25% | -3.48% | 39.26% | 71.19% | 47.29% | 64.06% | 210.74% | 123.69% |
| Conmed CNMD | 1.63B Small-cap | -4.87% | -3.69% | -1.27% | -15.16% | -23.65% | -31.66% | -37.37% | -33.17% |
Ownership & Short Interest
Insider Ownership
36.81%
Institutional Ownership
59.44%
Shares Short
152K
Short Ratio
2.60
Short % of Shares Outstanding
1.89%
Average 10-Day Volume
35K
Average 90-Day Volume
47K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is IRMD's 52-week high and low?
- In the last 52 weeks, Iridium reached a high of $74.43 (on September 11, 2025) and a low of $46.86 (on October 31, 2024).
- What is the market cap and P/E ratio for IRMD?
- Curious about Iridium's size and valuation? Its market capitalization stands at 908.97M. When it comes to valuation, the P/E ratio (trailing twelve months) is 44.39, and the forward P/E (looking ahead) is 40.83.
- Does IRMD pay dividends? If so, what's the yield?
- Yes, Iridium is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.15%, and the company has paid an average of $0.88 per share annually over the past 3 years.
- Who are Iridium's main competitors or similar companies to consider before investing?
When looking at Iridium, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT232.75B Healthcare Medical Devices 18.36% 33.66% Boston Scientific
BSX147.98B Healthcare Medical Devices 17.05% 152.52% Enovis
ENOV1.90B Healthcare Medical Devices -24.04% -30.98% Artivion
AORT1.88B Healthcare Medical Devices 64.06% 210.74% Conmed
CNMD1.63B Healthcare Medical Devices -31.66% -37.37% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Iridium Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Iridium's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 23.75%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at 78.17%.
- What is the recent revenue and earnings growth for IRMD?
- Looking at Iridium's growth, its revenue over the trailing twelve months (TTM) was $78M. Compared to the same quarter last year (YoY), quarterly revenue grew by 13.80%, and quarterly earnings saw a YoY growth of 17.80%.
- How much of IRMD stock is held by insiders and institutions?
- Wondering who owns Iridium stock? Company insiders (like executives and directors) hold about 36.81% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 59.44%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.